Capsule Bag Performance of a Novel Single-piece Acrylic IOL HOYA AF-1 NY-60
1 other identifier
interventional
42
1 country
1
Brief Summary
During the past decades, cataract surgery underwent tremendous change and modernisation resulting in today's small incision, phacoemulsification surgery and a safe technique with a short rehabilitation time for the patient. In this study the capsule performance and stability of a new one-piece microincisional hydrophobic acrylic IOL (HOYA AF-1 NY-60) should be assessed in subgroups of normal, short and long eyes. The IOL has a sharp optic edge design to inhibit PCO formation. Hypothesis: The novel haptic design is supposed to avoid tension folds in capsule bag, allow for a longer contact length of haptic with capsule equator, ensure rotational stability as well as good centration of the optic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2011
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 4, 2025
CompletedFirst Posted
Study publicly available on registry
September 11, 2025
CompletedSeptember 23, 2025
April 1, 2010
2.2 years
September 4, 2025
September 17, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Anterior chamber depth
4 times, each 5 minutes during procedure
Study Arms (1)
HOYA acrylic single-piece IOL (HOYA AF-1 NY-60)
OTHERInterventions
Eligibility Criteria
You may qualify if:
- Age-related cataract
- Age 21 and older
- Visual Acuity \> 0.05
- Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
You may not qualify if:
- Relevant other ophthalmic diseases especially those that may compromise capsule bag integrity or zonule stability (such as pseudoexfoliation syndrome, Marfan's syndrome, etc.)
- Preceding ocular surgery or trauma
- In case of pregnancy (pregnancy test will be taken preoperatively in women of reproductive age)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vienna Institute for Research in Ocular Surgery
Vienna, 1140, Austria
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 4, 2025
First Posted
September 11, 2025
Study Start
February 1, 2011
Primary Completion
May 1, 2013
Study Completion
December 1, 2013
Last Updated
September 23, 2025
Record last verified: 2010-04